Skip to content

Research on effect evaluation and neural mechanism of the staged integrated art-based cognitive intervention in elderly patients with cognitive impairment

Research on effect evaluation and neural mechanism of the staged integrated art-based cognitive intervention in elderly patients with cognitive impairment

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044959
Enrollment
Unknown
Registered
2021-04-03
Start date
2021-04-15
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients with cognitive impairment

Interventions

Sponsors

Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=60 years; 2. Meet the diagnostic criteria of SCD, MCI, and mild and moderate AD; 3. Those who can communicate normally in Mandarin and can cooperate to complete the scale assessment; 4. Volunteer to participate in this research.

Exclusion criteria

Exclusion criteria: 1. Persons with a history of mental illness or congenital mental retardation; 2. Patients with severe cardiopulmonary, liver and kidney dysfunction, severe endocrine diseases, severe infectious diseases, severe anemia and toxic encephalopathy; 3. Cerebrovascular disease, Parkinson's disease, brain trauma, encephalitis, epilepsy, brain tumor, long-term diarrhea or malnutrition (vitamin deficiency), thyroid dysfunction, blood transfusion or metallurgy history, alcoholism, CO poisoning, drug abuse, syphilis and AIDS, etc.; 4. Contraindications for MRI examination, such as accompanied by metal implants such as pacemaker, arterial stent, aneurysm clip, dental implant, claustrophobia and so on; 5. The patients who participated in MRI scanning were assessed as right-handed on the handedness scale.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment, MoCA;Mini-mental state examination, MMSE;

Secondary

MeasureTime frame
Auditory verbal learning test, AVLT;Verbal fluency tests, VFT;Boston naming test, BNT;Shape trails test, STT;Rey – Osterrieth complex figure test, ROCFT;Activity of daily living, ADL;Functional activities questionnaire,FAQ;Geriatric Depression Scale, GDS;Self-rating Anxiety Scale, SAS;Quality of life-Alzheimer's disease, QOL-AD;P300;MRI Scans;Blood biological indicators;

Countries

China

Contacts

Public ContactLi Hong

Fujian Medical University

leehong99@126.com+86 13705070219

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026